Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vomiting 24Nausea 20Breast Neoplasms 8Neoplasms 7Multiple Myeloma 5Lymphoma 5Ovarian Neoplasms 4Lymphoma, Non-Hodgkin 4Leukemia, Myeloid, Acute 4Myeloproliferative Disorders 3Carcinoma, Non-Small-Cell Lung 3Testicular Neoplasms 2Sezary Syndrome 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Neuroblastoma 2Neoplasms, Plasma Cell 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Neutrophilic, Chronic 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

Surveys and Questionnaires 5Pemetrexed 3Paclitaxel 3Gemcitabine 3Docetaxel 3Brachytherapy 3pembrolizumab 2Topotecan 2Saline Solution 2Radiotherapy 2Radiation 2FANG vaccine 2Everolimus 2Doxorubicin 2Cisplatin 2Carboplatin 2CP protocol 2temsirolimus 1selinexor 1osimertinib 1niraparib 1fosaprepitant 1ferumoxtran-10 1ferrous fumarate 1durvalumab 1cobimetinib 1atezolizumab 1alovudine 1Vitamin D 1Uterine Artery Embolization 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Uterine Neoplasms × Aprepitant × Clear all
NCT01432015 2017-03-28

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Gynecologic Oncology Associates

Phase 4 Completed
20 enrolled 5 charts
Gynecologic

Ovarian Neoplasms, Uterine Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡